Market Cap

CRISPR Therapeutics AG Market Capitalization:

$4.51 Billion

USD as of July 1, 2024

business CRISPR Therapeutics AG Company Profile

CRISPR Therapeutics AG Main Stock Listing

NASDAQ: CRSP

Market Capitalization History of CRISPR Therapeutics AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of CRISPR Therapeutics AG market cap

Date Market Cap YoY Change
Jan. 1, 2024 $4.82 B 29.69%
Jan. 1, 2023 $3.72 B -25.95%
Jan. 1, 2022 $5.02 B -61.53%
Jan. 1, 2021 $13.04 B 218.96%
Jan. 1, 2020 $4.09 B 60.19%
Jan. 1, 2019 $2.55 B -17.44%
Jan. 1, 2018 $3.09 B 121.30%
Jan. 1, 2017 $1.40 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

CRISPR Therapeutics AG Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

CRISPR Therapeutics AG has the following listings and related stock indices.


Stock: NASDAQ: CRSP

Stock: BMV: CRSPN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.